- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: MDI
Total 329 results
-
GlaxoSmithKlineCompleted
-
Arkansas Children's Hospital Research InstituteCompletedDiabetes MellitusUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Greece, Czechia
-
Amphastar Pharmaceuticals, Inc.CompletedAsthma | Shortness of Breath | Wheezing | BronchospasmUnited States
-
University of FloridaAmerican Heart AssociationCompletedHypertension | AgingUnited States
-
Pearl Therapeutics, Inc.Completed
-
Pearl Therapeutics, Inc.Completed
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Amphastar Pharmaceuticals, Inc.Completed
-
PfizerCompletedCrohn's DiseaseKorea, Republic of, Canada, United States, Spain, Netherlands, Australia, Israel, Croatia, Japan, Germany, Hungary, Bulgaria, Austria, Czech Republic, France, Greece, South Africa, Ukraine
-
Pearl Therapeutics, Inc.Completed
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
Amphastar Pharmaceuticals, Inc.Completed
-
Pearl Therapeutics, Inc.Completed
-
Amphastar Pharmaceuticals, Inc.CompletedAsthmaUnited States
-
Pearl Therapeutics, Inc.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
King's College LondonUniversity Hospital, Caen; University of LeicesterCompletedDiabetes Mellitus, Type 2
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Pearl Therapeutics, Inc.Completed
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Barnes-Jewish HospitalCompletedVentilator Associated PneumoniaUnited States
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompleted
-
SunovionTerminated
-
SunovionCompletedGeneralized Anxiety DisorderUnited States
-
Amphastar Pharmaceuticals, Inc.CompletedAsthmaUnited States
-
Abbott Diabetes CareCompletedDiabetes MellitusUnited Kingdom
-
GlaxoSmithKlineCompletedAsthmaUnited Kingdom, Netherlands
-
JhpiegoMerck Sharp & Dohme LLCCompletedCervical CancerPhilippines, Thailand
-
University of Colorado, DenverCompleted
-
University of CalgaryCanadian Institutes of Health Research (CIHR); The Arthritis Society, Canada; Smith and Nephew (formerly Oratec Interventions)Completed
-
Intech Biopharm Ltd.Completed
-
GlaxoSmithKlineCompleted
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Withdrawn
-
University of FloridaCompletedAcute Coronary Syndrome
-
Vastra Gotaland RegionNovo Nordisk A/SCompletedType 2 Diabetes MellitusSweden
-
Solvay PharmaceuticalsNektar TherapeuticsCompletedMigraine Without Aura | Migraine With AuraUnited States
-
Steen AndersenMedtronicCompletedType 1 Diabetes MellitusDenmark
-
University of California, San DiegoCompleted